187 related articles for article (PubMed ID: 23160466)
21. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
Manshouri T; Quintás-Cardama A; Nussenzveig RH; Gaikwad A; Estrov Z; Prchal J; Cortes JE; Kantarjian HM; Verstovsek S
Cancer Sci; 2008 Jun; 99(6):1265-73. PubMed ID: 18482053
[TBL] [Abstract][Full Text] [Related]
22. Abnormal adhesion of red blood cells in polycythemia vera: a prothrombotic effect?
El Nemer W; De Grandis M; Brusson M
Thromb Res; 2014 May; 133 Suppl 2():S107-11. PubMed ID: 24862129
[TBL] [Abstract][Full Text] [Related]
23. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
Menier C; Guillard C; Cassinat B; Carosella ED; Rouas-Freiss N
Leukemia; 2008 Mar; 22(3):578-84. PubMed ID: 18059484
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F.
Boissinot M; Cleyrat C; Vilaine M; Jacques Y; Corre I; Hermouet S
Oncogene; 2011 Feb; 30(8):990-1001. PubMed ID: 21042281
[TBL] [Abstract][Full Text] [Related]
25. Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera.
Gaikwad A; Prchal JT
Exp Hematol; 2007 Nov; 35(11):1647-56. PubMed ID: 17976517
[TBL] [Abstract][Full Text] [Related]
26. Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.
Hines PC; Zen Q; Burney SN; Shea DA; Ataga KI; Orringer EP; Telen MJ; Parise LV
Blood; 2003 Apr; 101(8):3281-7. PubMed ID: 12506027
[TBL] [Abstract][Full Text] [Related]
27. Altered Ca
Buks R; Dagher T; Rotordam MG; Monedero Alonso D; Cochet S; Gautier EF; Chafey P; Cassinat B; Kiladjian JJ; Becker N; Plo I; Egée S; El Nemer W
Cells; 2021 Dec; 11(1):. PubMed ID: 35011611
[TBL] [Abstract][Full Text] [Related]
28. [Molecular basis of red blood cell adhesion to endothelium].
Wautier JL; Wautier MP
Ann Pharm Fr; 2011 Jan; 69(1):3-6. PubMed ID: 21296212
[TBL] [Abstract][Full Text] [Related]
29. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells.
El Nemer W; Wautier MP; Rahuel C; Gane P; Hermand P; Galactéros F; Wautier JL; Cartron JP; Colin Y; Le Van Kim C
Blood; 2007 Apr; 109(8):3544-51. PubMed ID: 17158232
[TBL] [Abstract][Full Text] [Related]
30. Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.
Akada H; Yan D; Zou H; Fiering S; Hutchison RE; Mohi MG
Blood; 2010 Apr; 115(17):3589-97. PubMed ID: 20197548
[TBL] [Abstract][Full Text] [Related]
31. Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation.
Kamishimoto J; Tago K; Kasahara T; Funakoshi-Tago M
Cell Signal; 2011 May; 23(5):849-56. PubMed ID: 21255641
[TBL] [Abstract][Full Text] [Related]
32. Dimerization and phosphorylation of Lutheran/basal cell adhesion molecule are critical for its function in cell migration on laminin.
Guadall A; Cochet S; Renaud O; Colin Y; Le Van Kim C; de Brevern AG; El Nemer W
J Biol Chem; 2019 Oct; 294(41):14911-14921. PubMed ID: 31413112
[TBL] [Abstract][Full Text] [Related]
33. Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation.
Stetka J; Vyhlidalova P; Lanikova L; Koralkova P; Gursky J; Hlusi A; Flodr P; Hubackova S; Bartek J; Hodny Z; Divoky V
Oncogene; 2019 Jul; 38(28):5627-5642. PubMed ID: 30967632
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.
Berkofsky-Fessler W; Buzzai M; Kim MK; Fruchtman S; Najfeld V; Min DJ; Costa FF; Bischof JM; Soares MB; McConnell MJ; Zhang W; Levine R; Gilliland DG; Calogero R; Licht JD
Clin Cancer Res; 2010 Sep; 16(17):4339-52. PubMed ID: 20601445
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of vorinostat in a murine model of polycythemia vera.
Akada H; Akada S; Gajra A; Bair A; Graziano S; Hutchison RE; Mohi G
Blood; 2012 Apr; 119(16):3779-89. PubMed ID: 22408262
[TBL] [Abstract][Full Text] [Related]
36. B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease.
Zen Q; Batchvarova M; Twyman CA; Eyler CE; Qiu H; De Castro LM; Telen MJ
Am J Hematol; 2004 Feb; 75(2):63-72. PubMed ID: 14755370
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of erythrocyte adhesion to endothelial cells in diseases.
Wautier JL; Wautier MP
Clin Hemorheol Microcirc; 2013; 53(1-2):11-21. PubMed ID: 22941965
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera.
Mullally A; Poveromo L; Schneider RK; Al-Shahrour F; Lane SW; Ebert BL
Blood; 2012 Jul; 120(1):166-72. PubMed ID: 22627765
[TBL] [Abstract][Full Text] [Related]
39. Distinguishing essential thrombocythemia
Silver RT; Krichevsky S
Haematologica; 2019 Nov; 104(11):2200-2205. PubMed ID: 30948488
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of mast cells are involved in pruritus associated with polycythemia vera in JAK2V617F transgenic mice.
Jin X; Zhao W; Kirabo A; Park SO; Ho WT; Sayeski PP; Zhao ZJ
J Immunol; 2014 Jul; 193(2):477-84. PubMed ID: 24920845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
